Make Your Journey Better: The Baseus PrimeTrip C03 Magnetic Car Mount Series & VR2 Max 100W Car Charger
SHENZHEN, China, July 8, 2025 /PRNewswire/ — Innovation has always been a crucial component in creating unique and valuable products. While catering to growing... Read more.
iFFALCON Announces Prime Day Promotions on Mural TV Series with Up to 24% Off
IRVINE, Calif., July 8, 2025 /PRNewswire/ — In celebration of Prime Day 2025, iFFALCON, a global smart TV innovator and official Worldwide Olympic Partner,... Read more.
Alfa Laval completes acquisition of cryogenic business from French group Fives
LUND, Sweden, July 8, 2025 /PRNewswire/ — Alfa Laval has completed the acquisition of the cryogenics business unit of Fives (Fives Energy Cryogenics), a world-leading... Read more.
Clarifai Unveils “AI Runners”: Unmatched Flexibility for Local AI Deployment
WASHINGTON, July 8, 2025 /PRNewswire/ — Clarifai, a global leader in AI and pioneer of the full-stack AI platform, today announced the launch of AI Runners,... Read more.
WEKA Debuts NeuralMesh Axon For Exascale AI Deployments
New Offering Delivers a Unique Fusion Architecture That’s Being Leveraged by Industry-Leading AI Pioneers Like Cohere, CoreWeave, and NVIDIA to Deliver Breakthrough... Read more.
Broadridge Enabling Rapid Compliance with EU Instant Payments Regulations
Broadridge’s faster, cost-efficient access to the ECB’s TIPS service is accelerating financial institutions’ compliance with new EU Instant Payment... Read more.
LG ANNOUNCES AMBITION TO BECOME TOP-TIER GLOBAL HVAC SOLUTION PROVIDER
Accelerating B2B HVAC Leadership Through Industrial Solutions, Strategic Acquisitions and Localized Value Chains SEOUL, South Korea, July 8, 2025 /PRNewswire/ — LG... Read more.
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
SHANGHAI, July 7, 2025 /PRNewswire/ — WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and... Read more.
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and XGEVA® (denosumab)... Read more.
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 7, 2025 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious... Read more.